Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: Analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009

British Journal of Haematology

Volumn 157, Issue 6, 2012, Pages 742-746

  Snowden, John A ^a   Pearce, Rachel M ^b   Lee, Julia ^b   Kirkland, Keiren ^b   Gilleece, Maria ^c   Veys, Paul ^d   Clark, Richard E ^e   Kazmi, Majid ^f   Abinun, Mario ^g   Jackson, Graham H ^g   MacKinnon, Stephen ^h   Russell, Nigel H ⁱ   Cook, Gordon ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^e ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^h ROYAL FREE HOSPITAL   (United Kingdom)

ⁱ NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Autoimmune disease; Blood and marrow transplantation; Cell therapy; Stem cell transplantation; Stem cells

Indexed keywords

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHILD; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GREAT BRITAIN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; SOCIETIES, MEDICAL; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84861529082     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09122.x     Document Type: Article

References (15)

1. Burt, R.K., Marmont, A., Oyama, Y., Slavin, S., Arnold, R., Hiepe, F., Fassas, A., Snowden, J., Schuening, F., Myint, H., Patel, D.D., Collier, D., Heslop, H., Krance, R., Statkute, L., Verda, L., Traynor, A., Kozak, T., Hintzen, R.Q., Rose, J.W., Voltarelli, J., Loh, Y., Territo, M., Cohen, B.A., Craig, R.M., Varga, J. & Barr, W.G. (2006) Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis & Rheumatism, 54, 3750-3760.
2. Burt, R.K., Shah, S.J., Dill, K., Grant, T., Gheorghiade, M., Schroeder, J., Craig, R., Hirano, I., Marshall, K., Ruderman, E., Jovanovic, B., Milanetti, F., Jain, S., Boyce, K., Morgan, A., Carr, J. & Barr, W. (2011) Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial. Lancet, 378, 498-506.
3. Cook, G., Jackson, G.H., Morgan, G.J., Russell, N., Kirkland, K., Lee, J., Pearce, R., Marks, D.I., Pagliuca, A. & British Society for Blood and Marrow Transplantation (BSBMT) (2011) The outcome of high-dose chemotherapy and auto-SCT in patients with multiple myeloma: a UK/Ireland and European benchmarking comparative analysis. Bone Marrow Transplantation, 46, 1210-1218.
4. Daikeler, T., Hügle, T., Farge, D., Andolina, M., Gualandi, F., Baldomero, H., Bocelli-Tyndall, C., Brune, M., Dalle, J.H., Urban, C., Ehninger, G., Gibson, B., Linder, B., Lioure, B., Marmont, A., Matthes-Martin, S., Nachbaur, D., Schuetz, P., Tyndall, A., van Laar, J.M., Veys, P., Saccardi, R., Gratwohl, A. & Working Party Autoimmune Diseases of the EBMT (2009) Allogenic hematopoietic stem cell transplantation for patients with autoimmune diseases. Bone Marrow Transplantation, 44, 27-33.
5. Farge, D., Labopin, M., Tyndall, A., Fassas, A., Mancardi, G.L., Van Laar, J., Ouyang, J., Kozak, T., Moore, J., Kötter, I., Chesnel, V., Marmont, A., Gratwohl, A. & Saccardi, R. (2010) Autologous hematopoietic stem cell transplantation (HSCT) for autoimmune diseases: an observational study on 12 years of experience from the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Autoimmune Diseases. Haematologica, 95, 284-292.
6. Gratwohl, A., Baldomero, H., Aljurf, M., Pasquini, M.C., Bouzas, L.F., Yoshimi, A., Szer, J., Lipton, J., Schwendener, A., Gratwohl, M., Frauendorfer, K., Niederwieser, D., Horowitz, M., Kodera, Y. & Worldwide Network of Blood and Marrow Transplantation (2010) Hematopoietic stem cell transplantation: a global perspective. Journal of the American Medical Association, 303, 1617-1624.
7. Hinterberger, W., Hinterberger-Fischer, M. & Marmont, A. (2002) Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplantation, 30, 753-759.
8. Hough, R.E., Snowden, J.A. & Wulffraat, N.M. (2005) Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective. British Journal of Haematology, 128, 432-459.
9. Mancardi, G. & Saccardi, R. (2008) Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurology, 7, 626-636.
10. Marsh, J.C., Pearce, R.M., Ko, M., Tang, D., Lim, Z., Pagliuca, A., Mufti, G.J., Snowden, J., Vora, A., Gibson, B., Gilleece, M., Lee, J., Kirkland, K. & Cook, G. (2011) National, retrospective, multi-centre comparison of Alemtuzumab- versus ATG-based conditioning regimens in hematopoietic stem cell transplantation for aplastic anemia: a study from the British Society for Blood and Marrow Transplantation (BSBMT) (CTCR 09-03). Blood (ASH Annual Meeting Abstracts), 118, 52.
11. Sinha, G. (2007) United Kingdom becomes the cancer clinical trials recruitment capital of the world. Journal of the National Cancer Institute, 99, 420-422.
12. Snowden, J.A., Biggs, J.C. & Brooks, P.M. (1996) Autologous blood stem cell transplantation for autoimmune diseases. Lancet, 348, 1112-1113.
13. Snowden, J.A., Saccardi, R., Allez, M., Ardizzone, S., Arnold, R., Cervera, R., Denton, C., Hawkey, C., Labopin, M., Mancardi, G., Martin, R., Moore, J.J., Passweg, J., Peters, C., Rabusin, M., Rovira, M., van Laar, J.M. & Farge, D. (2011) Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation, doi: 10.1038/bmt.2011.185. [Epub ahead of print].
14. Sullivan, K.M., Muraro, P. & Tyndall, A. (2010) Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States. Biology of Blood and Marrow Transplantation, 16(1 Suppl), S48-S56.
15. Tyndall, A. & Gratwohl, A. (1997) Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation, 19, 643-645.